As concerns rise that the novel coronavirus infection (COVID-19) will resurge, GREEN Life Science recorded a price ceiling.

A woman receives a booster dose of Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) at the Police hospital in Bangkok./Courtesy of Reuters.

As of 9:33 a.m. on the 26th, GREEN Life Science has recorded a price ceiling at 3,720 won, an increase of 855 won (29.84%) from the previous transaction.

GREEN Life Science is a manufacturer of medical pharmaceuticals and pharmaceutical intermediates. It is also known as a supplier to Pfizer, which has a COVID-19 vaccine.

Recently, COVID-19, which had been resurging primarily in the Greater China region, is spreading across Asian countries, including Thailand. In particular, Taiwan has seen hospital visitors due to COVID-19 rise to 19,097, while Hong Kong has recorded over 1,000 COVID-19 patients. In China, the rate of positive diagnoses for COVID-19 among suspected influenza cases continues to increase.

※ This article has been translated by AI. Share your feedback here.